CNIPA.AI
返回搜索
档案

USE OF ARIMOCLOMOL IN ACTIVATING CLEAR GENE EXPRESSION AS TREATMENT FOR LYSOSOMAL STORAGE DISORDERS

发明专利审中
7浏览
31权利要求 · 7 独立
§ Ⅰ

卷宗概要

发明人

Sven Guenther; Travis Mickle; Thomas Kirkegaard Jensen

IPC 分类

A61K 31/4545A61K 31/445A61P 3/A61P 43/

CPC 分类

A61K31/4545A61K31/445A61P3/A61P43/

The present disclosure provides methods of treating lysosomal storage disorders such as Niemann-Pick Disease, Type-C, by administering a therapeutically effective amount of arimoclomol in combination with miglustat. The present disclosure further provides methods of removing lysosomal cholesterol by administering the same.

原文(中文)

The present disclosure provides methods of treating lysosomal storage disorders such as Niemann-Pick Disease, Type-C, by administering a therapeutically effective amount of arimoclomol in combination with miglustat. The present disclosure further provides methods of removing lysosomal cholesterol by administering the same.